ArticleBalkan medical journal2023
A New Approach to Exopolysaccharides of Post Probiotic
Article in Balkan medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
- Quorum quenching pathoblockers from bacteria: an alternative approach for bacterial infection management.Folia microbiologica · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multi-antibiotic resistance, which has increased in recent years, poses a serious societal threat as it makes the fight against deadly infection-causing pathogens even more complex and difficult. As such, the search for naturally resistant probiotic microorganisms and metabolic products obtained from these organisms to prevent infections, as an alternative to antibiotics, is crucial. In this context, preventing the quorum sensing (QS) mechanism that provides communication among bacteria is considered a mechanism that can prevent the colonization and progression of deadly infections. Aims: To determine the QS mechanism and the immunological effects and various biological and biochemical characterizations of exopolysaccharide (EPS) obtained from the Study Design: Experimental laboratory study. Methods: The antibacterial ability, the antibiofilm and QS forming activities, and interferon (IFN)-γ and interleukin (IL)-10 production capacities of EPS were determined. The total antioxidant capacity (TAC), the surface morphology of EPS by scanning electron microscopy (SEM), the presence of functional groups, and the monosaccharide composition were determined by gas chromatographymass spectrometry (GC-MS). Results: Conclusion: Interestingly, EPSs of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.